The only thing standing in the way of rare cancer is funding

A little affirmative action in the funding of research into rare cancers could go a long way, according to a new report from Rare Cancers Australia. The report, launched at their recent CanForum17, calls for a redistribution of research funds to build the evidence necessary to underpin the registration and reimbursement of new therapies.  Professor ...

Already a member?

Login to keep reading.

© 2022 the limbic